143 related articles for article (PubMed ID: 1589705)
1. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
Borody TJ; George LL; Brandl S; Andrews P; Lenne J; Moore-Jones D; Devine M; Walton M
Scand J Gastroenterol; 1992 Apr; 27(4):281-4. PubMed ID: 1589705
[TBL] [Abstract][Full Text] [Related]
2. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
Veldhuyzen Van Zanten S; Farley A; Marcon N; Lahaie R; Archambault A; Hunt R; Bailey R; Owen D; Spénard J; Stiglick A; Aimola N; Colin P
Can J Gastroenterol; 2000; 14(7):599-602. PubMed ID: 10978947
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the eradication of Helicobacter pylori with triple therapy.
Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
[TBL] [Abstract][Full Text] [Related]
4. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.
Roghani HS; Massarrat S; Pahlewanzadeh MR; Dashti M
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):709-12. PubMed ID: 10445787
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
6. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
Hosking SW; Ling TK; Chung SC; Yung MY; Cheng AF; Sung JJ; Li AK
Lancet; 1994 Feb; 343(8896):508-10. PubMed ID: 7906759
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
[TBL] [Abstract][Full Text] [Related]
8. Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Graham DY; Lew GM; Ramirez FC; Genta RM; Klein PD; Malaty HM
Aliment Pharmacol Ther; 1993 Feb; 7(1):111-3. PubMed ID: 8439632
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
[TBL] [Abstract][Full Text] [Related]
10. Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
Lahaie R; Farley A; Dallaire C; Archambault A; Fallone CA; Ponich T; Hunt R; Oravec M; Whitsitt P; Van Zanten SV; Marcon N; Bailey R; Dumont A; Nguyen B; Desrochers S; Spénard J
Can J Gastroenterol; 2001 Sep; 15(9):581-5. PubMed ID: 11573100
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Wang Z; Wu S
Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
[TBL] [Abstract][Full Text] [Related]
12. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
14. Triple-drug therapy of Helicobacter pylori infection in duodenal ulcer disease.
Dayal VM; Kumar P; Kamal J; Shahi SK; Agrawal BK
Indian J Gastroenterol; 1997 Apr; 16(2):46-8. PubMed ID: 9114569
[TBL] [Abstract][Full Text] [Related]
15. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
[TBL] [Abstract][Full Text] [Related]
16. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Salmanroghani H; Mirvakili M; Baghbanian M; Salmanroghani R; Sanati G; Yazdian P
PLoS One; 2018; 13(6):e0197096. PubMed ID: 29889843
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
20. What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Onal IK; Gokcan H; Benzer E; Bilir G; Oztas E
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):642-6. PubMed ID: 23796974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
